Skip to main content

ISO 10993-3:2014

Current Date published:

Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity

ISO 10993-3:2014 specifies strategies for risk estimation, selection of hazard identification tests and risk management, with respect to the possibility of the following potentially irreversible biological effects arising as a result of exposure to medical devices:

  • genotoxicity;
  • carcinogenicity;
  • reproductive and developmental toxicity.

ISO 10993-3:2014 is applicable when the need to evaluate a medical device for potential genotoxicity, carcinogenicity, or reproductive toxicity has been established.

Get this standard Prices exclude GST
PDF ( Single user document)
$301.00 NZD
HardCopy
$346.00 NZD
Networkable PDF
Price varies
Preview only close
Prev {{ page }}/ {{ numPages }} Next
Preview only close
Prev {{ page }}/ {{ numPages }} Next
Pages: 34

Previous versions

Keep me up-to-date

Sign up to receive updates when there are changes to this standard

Related Information

Similar Standards

Preview only close
Prev {{ page }}/ {{ numPages }} Next
Preview only close
Prev {{ page }}/ {{ numPages }} Next
Pages: 34

Previous versions

ISO 10993-3:2014

Get this standard Prices exclude GST
PDF ( Single user document)
$301.00 NZD
HardCopy
$346.00 NZD
Networkable PDF
Price varies

Request to add this standard to your subscription

ISO 10993-3:2014

Price varies
Online library subscription

Your organisation’s Account Administrator must approve a request to add a standard to your subscription.

You may add a comment to the administrator below.

Cancel